Hjem › Ulcerøs kolitt › Texas › San Antonio
Kliniske studier for Ulcerøs kolitt i San Antonio, TX
16 studier for Ulcerøs kolitt søker deltakere på steder i og rundt San Antonio (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
RekruttererFase 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekruttererFase 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruttererFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekruttererFase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekruttererFase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RekruttererObservasjonsstudie
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Ulcerøs kolitt-studier i andre byer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- Tacoma, WA15 studier
- Chicago, IL15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
- Washington, DC12 studier
Andre studier i San Antonio
- Ikke-småcellet lungekreft59 studier
- Kolorektal kreft46 studier
- Brystkreft46 studier
- Metastatisk kreft44 studier
- Kreft (alle typer)41 studier
- Fedme40 studier
- Type 2-diabetes37 studier
- Overvekt34 studier
- Eggstokkreft31 studier
- Pankreaskreft31 studier
- Prostatakreft28 studier
- Endometriekreft27 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.